大洋生物
(003017)
| 流通市值：18.93亿 | | | 总市值：22.86亿 |
| 流通股本：8348.11万 | | | 总股本：1.01亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 389,216,412.39 | 452,758,781.05 | 441,281,512.15 | 442,828,313.51 |
| 交易性金融资产 | 8,392,778.08 | 8,804,880.51 | 18,760,152.08 | - |
| 应收票据及应收账款 | 98,930,384.18 | 128,979,929.13 | 90,657,756.94 | 88,537,509.79 |
| 其中：应收票据 | 2,080,537.83 | 3,185,875.1 | 3,769,815.18 | 4,372,726.43 |
| 应收账款 | 96,849,846.35 | 125,794,054.03 | 86,887,941.76 | 84,164,783.36 |
| 应收款项融资 | 56,585,391.24 | 53,136,752.18 | 73,002,424.26 | 51,727,467.45 |
| 预付款项 | 37,997,523.48 | 31,569,490.67 | 23,371,823.99 | 38,558,998.22 |
| 其他应收款合计 | 2,047,614.49 | 1,712,478.97 | 1,445,811.59 | 1,129,093.53 |
| 存货 | 135,577,133.62 | 112,382,354.82 | 107,656,843.51 | 115,828,473.41 |
| 合同资产 | 0 | - | 0 | - |
| 其他流动资产 | 7,831,254.29 | 8,499,623.19 | 15,136,818.37 | 4,213,492 |
| 流动资产合计 | 736,578,491.77 | 797,844,290.52 | 771,313,142.89 | 742,823,347.91 |
| 非流动资产: | | | | |
| 长期股权投资 | 100,664,832.77 | 101,190,482.88 | 100,850,867.26 | 102,232,330.95 |
| 其他非流动金融资产 | - | - | 0 | 20,795,852.6 |
| 投资性房地产 | 139,828.01 | 139,828.01 | 139,828.01 | 139,828.01 |
| 固定资产 | 530,393,006.09 | 545,739,388.28 | 559,891,870.65 | 479,124,698.1 |
| 在建工程 | 373,648,780.76 | 282,648,724.21 | 238,933,840.36 | 258,106,907.78 |
| 使用权资产 | 1,551,044.03 | 1,753,354.1 | 1,955,664.17 | 2,157,974.24 |
| 无形资产 | 98,550,678.3 | 96,075,282.6 | 86,167,851.54 | 89,022,902.75 |
| 长期待摊费用 | 1,746,524.71 | 1,818,631.93 | 1,890,739.15 | 1,944,513.05 |
| 递延所得税资产 | 19,165,344.57 | 22,722,262.72 | 27,353,508.53 | 30,933,896.29 |
| 其他非流动资产 | 112,170,938.15 | 28,996,601.81 | 29,960,248.78 | 25,517,309.11 |
| 非流动资产合计 | 1,238,030,977.39 | 1,081,084,556.54 | 1,047,144,418.45 | 1,009,976,212.88 |
| 资产总计 | 1,974,609,469.16 | 1,878,928,847.06 | 1,818,457,561.34 | 1,752,799,560.79 |
| 流动负债: | | | | |
| 短期借款 | 414,090,647.81 | 377,833,887.25 | 345,252,301.1 | 331,125,424.28 |
| 应付票据及应付账款 | 272,921,238.89 | 223,511,201.97 | 225,387,028.53 | 184,061,250.14 |
| 其中：应付票据 | 122,546,580.87 | 109,416,177.26 | 77,145,259.13 | 69,174,608.32 |
| 应付账款 | 150,374,658.02 | 114,095,024.71 | 148,241,769.4 | 114,886,641.82 |
| 预收款项 | - | - | 22,395.32 | 12,250 |
| 合同负债 | 7,397,366.38 | 9,725,213.94 | 5,059,080.03 | 6,032,900.32 |
| 应付职工薪酬 | 17,448,859.86 | 12,684,570.9 | 21,847,859.8 | 18,273,988.92 |
| 应交税费 | 4,482,912.22 | 7,630,875.04 | 17,061,353.3 | 10,523,556.65 |
| 其他应付款合计 | 16,196,323.36 | 15,786,156.71 | 14,718,884.63 | 52,906,160.64 |
| 应付股利 | - | - | - | 25,200,000 |
| 其他流动负债 | 2,598,091 | 4,063,017.63 | 3,227,032.85 | 3,069,261.31 |
| 流动负债合计 | 735,135,439.52 | 651,234,923.44 | 632,575,935.56 | 606,004,792.26 |
| 非流动负债: | | | | |
| 长期借款 | 37,018,197.37 | 27,516,506.84 | 20,011,983.96 | 13,507,895.21 |
| 租赁负债 | 1,233,658.17 | 1,636,753.27 | 1,636,753.27 | 2,033,279.21 |
| 递延收益 | 6,846,711.54 | 7,178,719.74 | 7,510,727.94 | 7,854,192.19 |
| 递延所得税负债 | 18,116,441.43 | 19,165,461.11 | 19,980,249.42 | 21,416,858.84 |
| 非流动负债合计 | 63,215,008.51 | 55,497,440.96 | 49,139,714.59 | 44,812,225.45 |
| 负债合计 | 798,350,448.03 | 706,732,364.4 | 681,715,650.15 | 650,817,017.71 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 100,800,000 | 84,000,000 | 84,000,000 | 84,000,000 |
| 资本公积 | 535,303,424.61 | 548,943,431.12 | 545,791,044.39 | 545,358,036.78 |
| 减:库存股 | 6,133,411.9 | 6,133,411.9 | 6,133,411.9 | 18,318,193.04 |
| 专项储备 | 4,509,561.34 | 3,860,633.49 | 3,027,918.81 | 4,325,684.92 |
| 盈余公积 | 42,000,000 | 42,000,000 | 42,000,000 | 41,973,298.77 |
| 未分配利润 | 495,226,618.34 | 494,393,624.54 | 462,957,274.55 | 440,132,106.66 |
| 归属于母公司股东权益合计 | 1,171,706,192.39 | 1,167,064,277.25 | 1,131,642,825.85 | 1,097,470,934.09 |
| 少数股东权益 | 4,552,828.74 | 5,132,205.41 | 5,099,085.34 | 4,511,608.99 |
| 股东权益合计 | 1,176,259,021.13 | 1,172,196,482.66 | 1,136,741,911.19 | 1,101,982,543.08 |
| 负债和股东权益合计 | 1,974,609,469.16 | 1,878,928,847.06 | 1,818,457,561.34 | 1,752,799,560.79 |
| 公告日期 | 2026-08-25 | 2026-04-28 | 2026-04-28 | 2025-10-21 |
| 审计意见(境内) | | | 标准无保留意见 | |